21
S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Condition(s): Malignant Mesothelioma Last Updated: April 16, 2013Active, not recruiting
281 Clinical Trials for: “United States”, “Wyoming”, Page 2 of 15
Hide Studies Not Seeking New Volunteers
22
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Condition(s): Liver Cancer Last Updated: June 17, 2012Active, not recruiting
23
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
Condition(s): Adenocarcinoma of the Extrahepatic Bile Duct; Adenocarcinoma of the Gallbladder; Adenocarcinoma With Squamous Metaplasia of the Gallbladder; Anaplastic Carcinoma of the Gallbladder; Cholangiocarcinoma of the Extrahepatic Bile Duct; Cholangiocarcinoma of the Gallbladder; Recurrent Extrahepatic Bile Duct Cancer; Recurrent Gallbladder Cancer; Unresectable Extrahepatic Bile Duct Cancer; Unresectable Gallbladder Cancer Last Updated: March 18, 2013Active, not recruiting
24
Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer
Condition(s): Breast Cancer Last Updated: December 14, 2012Active, not recruiting
25
Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
Condition(s): Lymphoma Last Updated: June 6, 2012Active, not recruiting
26
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Condition(s): Adult Anaplastic Oligodendroglioma; Adult Mixed Glioma; Adult Oligodendroglioma; Recurrent Adult Brain Tumor Last Updated: January 14, 2013Active, not recruiting
27
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Condition(s): Neuroendocrine Carcinoma Last Updated: March 18, 2013Active, not recruiting
28
Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery
Condition(s): Pancreatic Cancer Last Updated: June 17, 2012Completed
29
Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma
Condition(s): Lymphoma Last Updated: August 3, 2012Active, not recruiting
30
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Condition(s): Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma Last Updated: January 14, 2013Recruiting
31
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Condition(s): Distal Urethral Cancer; Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter; Proximal Urethral Cancer; Recurrent Bladder Cancer; Recurrent Prostate Cancer; Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter; Recurrent Urethral Cancer; Stage IV Bladder Cancer; Stage IV Prostate Cancer; Transitional Cell Carcinoma of the Bladder; Urethral Cancer Associated With Invasive Bladder Cancer Last Updated: May 14, 2013Recruiting
32
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
Condition(s): Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Secondary Acute Myeloid Leukemia; Untreated Adult Acute Myeloid Leukemia Last Updated: May 6, 2013Recruiting
33
Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
Condition(s): Pancreatic Cancer Last Updated: May 10, 2011Completed
34
S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
Condition(s): Multiple Myeloma; Plasma Cell Myeloma Last Updated: January 2, 2013Active, not recruiting
35
S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Condition(s): Leukemia Last Updated: February 12, 2013Active, not recruiting
36
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Condition(s): Adenocarcinoma of the Colon; Stage II Colon Cancer Last Updated: March 22, 2013Active, not recruiting
37
Dinaciclib in Treating Patients With Stage IV Melanoma
Condition(s): Acral Lentiginous Malignant Melanoma; Lentigo Maligna Malignant Melanoma; Mucosal Melanoma; Nodular Malignant Melanoma; Recurrent Melanoma; Stage IV Melanoma; Superficial Spreading Malignant Melanoma Last Updated: May 1, 2013Active, not recruiting
38
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Condition(s): Light Chain Deposition Disease; Smoldering Multiple Myeloma Last Updated: May 1, 2013Recruiting
39
S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
Condition(s): Bladder Cancer Last Updated: November 19, 2012Active, not recruiting
40
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition(s): Extensive Stage Small Cell Lung Cancer; Recurrent Small Cell Lung Cancer Last Updated: December 3, 2012Active, not recruiting
